Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the Tilray board of directors approved an amendment to the Company's bylaws to reduce the quorum requirement for shareholder meetings from shareholders representing a majority of the voting power of the outstanding shares entitled to vote to one-third of the voting power of the outstanding shares entitled to vote. In conn

Tilray Board of Directors Announces Approval of Amendment to Company's Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement

Aphria

Aphria Inc. (TSX:APHA) (NASDAQ:APHA) confirmed Thursday it has satisfied one of the requirements for its merger with Tilray Inc. (NASDAQ:TLRY) after its shareholders approved the arrangement at a special meeting. The special resolution approving the arrangement had to be endorsed by a minimum of two-thirds (66.6%) of the votes cast at the meeting.

Aphria One Step Closer To Merging With Tilray, Shareholders Overwhelmingly Approve The Deal

Tilray Inc. said Thursday the special shareholder meeting to allow a vote on the Canadian cannabis company's proposed merger with rival Aphria Inc. has been adjourned to April 30 from April 16. The meeting will be held via live webast starting at 11.00 a.m.

Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the special meeting of Tilray stockholders (the “Tilray Special Meeting”) scheduled for Friday, April 16, 2021 via live webcast will be convened and then adjourned until Friday, April 30, 2021 at 11:00 a.m. Eastern time via live webcast at www.virtualshareholdermeeting.com/TLRY2021SM, allowing Tilray stockholders addition

Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11:00 a.m. Eastern Time

Shares of TLRY stock have been on what investors can only call a very bumpy ride of late, as price discovery continues for Tilray. The post Tilray's Volatility Can Be Your Friend, But Carries Downside Risk appeared first on InvestorPlace.

Tilray's Volatility Can Be Your Friend, But Carries Downside Risk

GrowGeneration Corp

SNDL Inc.

Pot stocks have been pulling back after Aphria Inc (NASDAQ:APHA) posted less than spectacular results earlier this week. That helped to break down the main industry ETFs and shake out the remaining speculative interest in the space.

Cannabis Stocks Show Fresh Life Following Corrective Dip (NASDAQ: TLRY) (OTC US: CRLBF) (OTC US: MEDH) (NASDAG: SNDL) (OTC US: GRWG) (NASDAQ: APHA)

TLRY stock and APHA stock are moving in different directions due to a merger arbitrage opportunity but there is a long-term opportunity here. The post Play Tilray Stock for the Aphria Stock Merger Arbitrage Opportunity appeared first on InvestorPlace.

Play Tilray Stock for the Aphria Stock Merger Arbitrage Opportunity

Aurora Cannabis

Canopy Growth

Cronos Group

Akerna Corp

Cannabis software firm Akerna Corp (NASDAQ:KERN) expects national cannabis retail sales to reach $95 million on 4/20, the unofficial marijuana holiday. That is according to a new Flash Report out of the Denver-based company.

Cannabis Sales Expected To Hit $370M In 5 Days Leading Up To 420

Coca-Cola

Virgin Galactic

Block

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Here's Why Virgin Galactic, Coca-Cola, Square, Tilray, Aphria Are Moving

Amplify Alternative Harvest ETF

AdvisorShares Pure Cannabis ETF 

The stock market was slightly lower to start the week.

Why Marijuana Stocks Went to Pot Monday

Curaleaf Holdings, Inc.

GameStop

HEXO Corp

Innovative Industrial Properties

Cambria Cannabis ETF

Top marijuana stocks fell further after Aphria reported results that missed expectations as coronavirus lockdowns hit sales. The post Are Any Marijuana Stocks Good Buys As Covid Concerns Resurface In Canada?

Are Any Marijuana Stocks Good Buys As Covid Concerns Resurface In Canada?

Cannabis stocks are suffering as Aphria's Q3 report leaves investors unsatisfied and the industry is held up by a lack of U.S. legalization. The post Cannabis Stocks: Why GRWG, SNDL, CGC, TLRY, APHA Stocks Are Getting Smoked appeared first on InvestorPlace.

Cannabis Stocks: Why GRWG, SNDL, CGC, TLRY, APHA Stocks Are Getting Smoked

United Continental Hlds

United Airlines Holdings Inc (NASDAQ: UAL) shares are trading lower by 3% Monday morning after the company said it expects first-quarter revenue to fall 66%, compared with its prior forecast of down 65%-70%. Extended lockdowns in Germany and a surge in India cases have potentially added to travel uncertainty.

Here's Why United Airlines, Tilray And Aphria Are Moving

Aphria's poor third-quarter performance is weighing on both cannabis stocks.

Why Aphria and Tilray Stocks Are Tanking Today

Success in the competitive cannabis space will require lots of scale. TLRY stock will have that when the company's merger is complete.

The Aphria Merger Will Change Everything For Tilray

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today reminds that holders (the “Shareholders”) of Tilray common shares (the “Shares”) vote FOR the proposals to complete the business combination between Aphria Inc. and Tilray (the “Transaction”). Tilray Shareholders who held Shares as of the March 12, 2021 record date are eligible to vote those Shares at the April 16, 2021 Tilray special me

MAKE YOUR VOTE COUNT!: Tilray Reminds Shareholders to Vote FOR the Proposed Business Combination With Aphria Inc.

With its APHA merger nearly agreed upon, TLRY stock should look for, and actually cheer for, any pullbacks in the stock price. The post Tilray Bulls Should Chill and Root for Pullbacks Ahead Of Aphria Merger appeared first on InvestorPlace.

Tilray Bulls Should Chill and Root for Pullbacks Ahead Of Aphria Merger

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

The global pandemic and following lockdowns impacted almost every sector of the economy. And the Canadian cannabis industry was no exception.

Cannabis Analyst: March Earning Season May Not Push Canadian LPs, But There Are Other Catalysts

3 Best Marijuana Stocks so Far This Year: Are They Buys Now?

Tilray, Inc. (TLRY) closed the most recent trading day at $19.77, moving +0.05% from the previous trading session.

Tilray, Inc. (TLRY) Gains But Lags Market: What You Should Know

Even with the global legalization trend, and its upcoming merger, you should consider other cannabis plays over TLRY stock. The post Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid appeared first on InvestorPlace.

Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid

Current and prospective TLRY stock holders need to get ready for a shareholder meeting that could be an industry game changer. The post Mark Your Calendars for an Upcoming Explosion by Tilray Stock appeared first on InvestorPlace.

Mark Your Calendars for an Upcoming Explosion by Tilray Stock

Transformative changes are afoot, but they might take time to pay off.

Should You Buy Tilray in April?

Tilray Inc's (NASDAQ:TLRY) stock lost a key technical level Wednesday after trading in a bearish pattern for eight weeks. The cannabis company's stock skyrocketed 166% over the course of five trading sessions in February but returned to ground level two weeks later.

News for Tilray Brands Stock (TLRY)